CME

AVOID

CME Group Inc.

Financials

1.83

PEGY ratio

Rank #341

Why This Matters

This stock appears overvalued relative to its growth and dividend yield. Moderate projected growth of 10.0% annually. Pays a 2.0% dividend yield.

CME trades at 22.0x earnings against 10.0% growth + 2.0% yield (PEGY 1.83). The valuation appears stretched relative to the available growth and income.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-06-02

Valuation

22.0x

P/E Ratio

Growth

10.0%

5yr EPS

Income

2.0%

Div Yield

PEGY Components

PEGY Score1.83

Denominator12.0%

EPS (TTM)$11.73

Market Data

Price$257.76

ExchangeNASDAQ

S&P 500Nasdaq 100

What Changed

PEGY Score

2.07→1.83(-0.25)

Rank

#358→#341(+17 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Financials

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only